{
    "nctId": "NCT05128617",
    "briefTitle": "Acute Effects of Chemotherapy Administration on Skeletal Muscle of Breast Cancer Patients: the PROTECT-06 Study",
    "officialTitle": "Acute Effects of Chemotherapy Administration on Skeletal Muscle of Breast Cancer Patients: the PROTECT-06 Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 20,
    "primaryOutcomeMeasure": "Investigate the acute effect of chemotherapy administration on protein turnover cellular processes through vastus lateralis biopsies of breast cancer patients",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Breast cancer (stade I to III)\n* Patient recieving the first administration of epirubicin-cyclophosphamide (group 1) or paclitaxel (group 2) for early breast cancer treatment\n\nExclusion Criteria:\n\n* History of cancer\n* Known chronic pathology\n* Pacemaker\n* Contraindication to the evaluation of the physical condition\n* Contraindication to the local anesthesia for the muscle micro-biopsy\n* Breastfeeding or pregnant woman",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}